ClinicalTrials.govpublic full text
MRG003 With Gemcitabine for Second-line Advanced PDAC
pancreatic ductal adenocarcinoma (pdac), second line treatment, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 900190
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.